TTK Healthcare Limited has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Limited regarding an upcoming board meeting and trading window closure.
The disclosure states that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, October 30, 2026. The primary agenda for this meeting includes considering and approving the Unaudited Financial Results of the Company for the Second Quarter ended September 30, 2026.
In connection with the board meeting and results announcement, the Company has implemented a trading window closure pursuant to its Code of Conduct framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in shares of the Company will remain closed for persons specified under the Code from October 01, 2026 to November 01, 2026 (both days inclusive).
All Designated Persons of the Company and their immediate relatives have been formally intimated not to trade in the Company's shares during this period of Trading Window closure.
The disclosure is made pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015. The document is signed by Gowry A Jaishankar, DGM – Legal & Company Secretary, with a digital signature timestamped October 23, 2026 at 15:59:45 +05'30'.